Your browser doesn't support javascript.
loading
Individualized 3D-printed applicators for magnetic resonance imaging-guided brachytherapy in nasal vestibule cancer.
de Ridder, Mischa; Smolic, Milena; Kastelijns, Maarten; Kloosterman, Samantha; van der Vegt, Stefan; Rijken, Johannes A; Jürgenliemk-Schulz, Ina M; Dehnad, Homan; Kroon, Petra S; Moerland, Marinus A.
Afiliação
  • de Ridder M; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Smolic M; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Kastelijns M; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Kloosterman S; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • van der Vegt S; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Rijken JA; Department of Head and Neck Surgical Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Jürgenliemk-Schulz IM; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Dehnad H; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Kroon PS; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
  • Moerland MA; Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands.
Phys Imaging Radiat Oncol ; 31: 100629, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39257571
ABSTRACT
Background and

purpose:

Brachytherapy is treatment of choice for early stage nasal vestibule cancer. Over the years improvements were achieved by means of image guided target definition, interstitial implant techniques and also individual mold techniques. The aim of this study was to improve the technique of the implant so that the need for interstitial catheters can be limited by making use of patient individualized 3D-printed applicators. Materials and

Methods:

In 19 patients 3D-printed applicators were used to deliver pulse dose rate (PDR) brachytherapy. All patients underwent computed tomography (CT) and magnetic resonance imaging (MRI). A pre-plan with tumor delineation and manually optimized catheter positions to achieve tumor coverage was made. Based on the pre-plan a 3D-printed applicator was manufactured. Dose was evaluated by several indices Conformity Index, Healthy Tissues Conformity Index, Dose Homogeneity Index, Dose non-uniformity ratio, Conformal index and high dose (HD) index.

Results:

A high target coverage was achieved, with a median V100%CTV of 99.1 % (range, 81.8-100 %) and median CI of 0.99 (range, 0.82-1.00), as well as a median V0.7GyGTV of 100 % (range, 93.0-100 %). The median HD was 0.39 (range, 0.20-0.83). Interstitial catheters were needed in 12 patients. None of the patients developed grade ≥ II toxicity within the median follow up of 18 months.

Conclusions:

This study shows that using 3D-printed applicators limits the need for interstitial catheters and also limits the high doses in normal tissue.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article